老年患者急性扁桃体咽炎的治疗:复杂局部治疗的几个方面。

Q3 Medicine
T Yu Vladimirova, A B Martynova
{"title":"老年患者急性扁桃体咽炎的治疗:复杂局部治疗的几个方面。","authors":"T Yu Vladimirova, A B Martynova","doi":"10.17116/otorino20259004119","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Infectious and inflammatory diseases of the pharynx remain the focus of attention of physicians of many specialties due to their high prevalence and social significance.</p><p><strong>Material and methods: </strong>The main group (<i>n</i>=30, mean age 68.9±5.6 years) was prescribed Dorithricin for resorption, 1 tablet every 3 hours, no more than 6 tablets per day for 6 days. The control group (<i>n</i>=30, mean age 68.3±4.7 years) was recommended treatment with antiviral and antipyretic agents.</p><p><strong>Results: </strong>By the 2nd visit, 16.7% of elderly patients experienced complete relief of sore throat, and no cases of high-intensity sore throat were recorded. By the 3rd day of treatment, the proportion of such patients increased significantly, amounting to 43.3%, and by the end of treatment, 96.7% of patients taking Dorithricin had no sore throat. The most significant changes during treatment were noted in relation to such additional symptoms as discomfort when swallowing and dysphagia. When assessing the pharyngoscopic picture, statistically significant differences were noted between the groups by the 2nd visit in relation to hyperemia of the oropharyngeal mucosa (<i>p</i>=0.048), the severity of edema of the oropharyngeal mucosa (<i>p</i>=0.043). Patients who received Dorithricin rated their satisfaction with the treatment as satisfied and extremely satisfied in 33.3% and 66.7%, the assessment of doctors was comparable.</p><p><strong>Conclusion: </strong>This study may contribute to the confidence of physicians in prescribing the complex drug Dorithricin, which includes substances that affect all key components of the pathogenesis of acute tonsillopharyngitis in elderly patients and increase patient satisfaction and expectations.</p>","PeriodicalId":23575,"journal":{"name":"Vestnik otorinolaringologii","volume":"90 4","pages":"19-26"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Treatment of acute tonsillopharyngitis in elderly patients: aspects of complex topical therapy].\",\"authors\":\"T Yu Vladimirova, A B Martynova\",\"doi\":\"10.17116/otorino20259004119\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Infectious and inflammatory diseases of the pharynx remain the focus of attention of physicians of many specialties due to their high prevalence and social significance.</p><p><strong>Material and methods: </strong>The main group (<i>n</i>=30, mean age 68.9±5.6 years) was prescribed Dorithricin for resorption, 1 tablet every 3 hours, no more than 6 tablets per day for 6 days. The control group (<i>n</i>=30, mean age 68.3±4.7 years) was recommended treatment with antiviral and antipyretic agents.</p><p><strong>Results: </strong>By the 2nd visit, 16.7% of elderly patients experienced complete relief of sore throat, and no cases of high-intensity sore throat were recorded. By the 3rd day of treatment, the proportion of such patients increased significantly, amounting to 43.3%, and by the end of treatment, 96.7% of patients taking Dorithricin had no sore throat. The most significant changes during treatment were noted in relation to such additional symptoms as discomfort when swallowing and dysphagia. When assessing the pharyngoscopic picture, statistically significant differences were noted between the groups by the 2nd visit in relation to hyperemia of the oropharyngeal mucosa (<i>p</i>=0.048), the severity of edema of the oropharyngeal mucosa (<i>p</i>=0.043). Patients who received Dorithricin rated their satisfaction with the treatment as satisfied and extremely satisfied in 33.3% and 66.7%, the assessment of doctors was comparable.</p><p><strong>Conclusion: </strong>This study may contribute to the confidence of physicians in prescribing the complex drug Dorithricin, which includes substances that affect all key components of the pathogenesis of acute tonsillopharyngitis in elderly patients and increase patient satisfaction and expectations.</p>\",\"PeriodicalId\":23575,\"journal\":{\"name\":\"Vestnik otorinolaringologii\",\"volume\":\"90 4\",\"pages\":\"19-26\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vestnik otorinolaringologii\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17116/otorino20259004119\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vestnik otorinolaringologii","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17116/otorino20259004119","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

咽部感染性和炎症性疾病由于其高患病率和社会意义,一直是许多专科医生关注的焦点。材料与方法:主要组患者30例,平均年龄(68.9±5.6)岁,口服甲氧甲苷促进吸收,每3 h 1片,每天不超过6片,连用6 d。对照组患者30例,平均年龄68.3±4.7岁,推荐使用抗病毒和退烧药治疗。结果:第二次访视时,16.7%的老年患者咽喉炎症状完全缓解,无高强度咽喉炎病例。到治疗第3天,这类患者的比例明显增加,达到43.3%,到治疗结束时,96.7%的服用哆里霉素的患者没有喉咙痛。治疗期间最显著的变化是与吞咽不适和吞咽困难等附加症状有关。在评估咽镜图像时,两组在第二次就诊时口咽黏膜充血(p=0.048)和口咽黏膜水肿严重程度(p=0.043)方面差异有统计学意义。接受多柔霉素治疗的患者对治疗的满意度分别为满意和极满意的占33.3%和66.7%,医生评价具有可比性。结论:本研究可提高医生在处方复方药物多orithricin时的信心,该复方药物包括影响老年急性扁桃体咽炎发病机制的所有关键成分的物质,提高患者的满意度和期望值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Treatment of acute tonsillopharyngitis in elderly patients: aspects of complex topical therapy].

Introduction: Infectious and inflammatory diseases of the pharynx remain the focus of attention of physicians of many specialties due to their high prevalence and social significance.

Material and methods: The main group (n=30, mean age 68.9±5.6 years) was prescribed Dorithricin for resorption, 1 tablet every 3 hours, no more than 6 tablets per day for 6 days. The control group (n=30, mean age 68.3±4.7 years) was recommended treatment with antiviral and antipyretic agents.

Results: By the 2nd visit, 16.7% of elderly patients experienced complete relief of sore throat, and no cases of high-intensity sore throat were recorded. By the 3rd day of treatment, the proportion of such patients increased significantly, amounting to 43.3%, and by the end of treatment, 96.7% of patients taking Dorithricin had no sore throat. The most significant changes during treatment were noted in relation to such additional symptoms as discomfort when swallowing and dysphagia. When assessing the pharyngoscopic picture, statistically significant differences were noted between the groups by the 2nd visit in relation to hyperemia of the oropharyngeal mucosa (p=0.048), the severity of edema of the oropharyngeal mucosa (p=0.043). Patients who received Dorithricin rated their satisfaction with the treatment as satisfied and extremely satisfied in 33.3% and 66.7%, the assessment of doctors was comparable.

Conclusion: This study may contribute to the confidence of physicians in prescribing the complex drug Dorithricin, which includes substances that affect all key components of the pathogenesis of acute tonsillopharyngitis in elderly patients and increase patient satisfaction and expectations.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Vestnik otorinolaringologii
Vestnik otorinolaringologii Medicine-Otorhinolaryngology
CiteScore
0.80
自引率
0.00%
发文量
69
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信